Prior treatment with inhaled corticosteroids in patients with respiratory disorders who develop community acquired pneumonia (CAP) is associated with a lower incidence and severity of parapneumonic effusion.

EXTON, Pa., Nov.

CONTACT: Alan Robertson - Chief Executive OfficerPh: +61 2 9454 7200 or email alan.robertson@pharmaxis.com.auRELEASED THROUGH:Australia:

EXTON, Pa., Feb.

SAN DIEGO, Nov. 11, 2010 /PRNewswire/ -- NexBio, Inc. announced the presentation of new data at the 2010 annual American College of Allergy, Asthma, and Immunology in Phoenix, Arizona.